Vanda Pharmaceuticals Inc (VNDA)
4.975
-0.26
(-5.06%)
USD |
NASDAQ |
Apr 18, 16:00
4.93
-0.04
(-0.90%)
After-Hours: 20:00
Vanda Pharmaceuticals Cash from Investing (TTM): -12.06M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -12.06M |
| September 30, 2023 | 107.16M |
| June 30, 2023 | 50.05M |
| March 31, 2023 | 226.35M |
| December 31, 2022 | 49.92M |
| September 30, 2022 | -51.50M |
| June 30, 2022 | -46.31M |
| March 31, 2022 | -65.90M |
| December 31, 2021 | -76.70M |
| September 30, 2021 | -67.38M |
| June 30, 2021 | -98.64M |
| March 31, 2021 | -61.73M |
| December 31, 2020 | -41.50M |
| September 30, 2020 | -31.04M |
| June 30, 2020 | 2.928M |
| March 31, 2020 | -11.56M |
| December 31, 2019 | -68.31M |
| September 30, 2019 | -77.88M |
| June 30, 2019 | -72.91M |
| March 31, 2019 | -162.42M |
| December 31, 2018 | -109.66M |
| September 30, 2018 | -86.50M |
| June 30, 2018 | -72.19M |
| March 31, 2018 | 23.25M |
| December 31, 2017 | -10.23M |
| Date | Value |
|---|---|
| September 30, 2017 | -9.458M |
| June 30, 2017 | -12.49M |
| March 31, 2017 | -19.96M |
| December 31, 2016 | -10.02M |
| September 30, 2016 | -13.74M |
| June 30, 2016 | -16.39M |
| March 31, 2016 | -0.258M |
| December 31, 2015 | -26.60M |
| September 30, 2015 | -59.52M |
| June 30, 2015 | -53.53M |
| March 31, 2015 | -45.99M |
| December 31, 2014 | -12.04M |
| September 30, 2014 | -49.22M |
| June 30, 2014 | -54.95M |
| March 31, 2014 | -64.36M |
| December 31, 2013 | -34.28M |
| September 30, 2013 | 29.52M |
| June 30, 2013 | 49.81M |
| March 31, 2013 | 47.37M |
| December 31, 2012 | 45.75M |
| September 30, 2012 | 87.59M |
| June 30, 2012 | 84.41M |
| March 31, 2012 | 89.38M |
| December 31, 2011 | 73.75M |
| September 30, 2011 | -22.34M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-98.64M
Minimum
Jun 2021
226.35M
Maximum
Mar 2023
-18.26M
Average
-46.31M
Median
Jun 2022
Cash from Investing (TTM) Benchmarks
| ADMA Biologics Inc | -4.981M |
| Johnson & Johnson | 878.00M |
| Nektar Therapeutics | 139.56M |
| Invivyd Inc | 280.68M |
| Amicus Therapeutics Inc | 98.06M |